EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹224 Cr | ₹227 Cr | ₹202 Cr | ₹178 Cr | ₹135 Cr |
What is the latest Total Liabilities ratio of EVEREST ORGANICS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹224 Cr |
| Mar2024 | ₹227 Cr |
| Mar2023 | ₹202 Cr |
| Mar2022 | ₹178 Cr |
| Mar2021 | ₹135 Cr |
How is Total Liabilities of EVEREST ORGANICS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹224 Cr | -0.94 | |
| Mar2024 | ₹227 Cr | 12.27 | |
| Mar2023 | ₹202 Cr | 13.40 | |
| Mar2022 | ₹178 Cr | 31.48 | |
| Mar2021 | ₹135 Cr | - | |
Compare Total Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹244.8 Cr | -5.7% | 5.3% | -42.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,893.0 Cr | -0.2% | 7.5% | 5.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,367.0 Cr | -0.9% | 11.5% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,241.0 Cr | 0.5% | 7% | 37.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,010.0 Cr | -3.1% | 4.8% | 10.3% | Stock Analytics | |
| CIPLA | ₹104,366.0 Cr | -5.4% | 5.5% | -13.5% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -5.7% |
5.3% |
-42.1% |
| SENSEX | -3.2% |
-3.9% |
-7.5% |
You may also like the below Video Courses